We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

83 hedge funds and large institutions have $136M invested in Infinity Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

97% more capital invested

Capital invested by funds: $68.9M → $136M (+$66.9M)

51% more funds holding

Funds holding: 55 → 83 (+28)

7% less call options, than puts

Call options by funds: $1.66M | Put options by funds: $1.78M

Holders
83
Holders Change
+28
Holders Change %
+50.91%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
25
Reduced
9
Closed
9
Calls
$1.66M
Puts
$1.78M
Net Calls
-$124K
Net Calls Change
-$117K

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$21.9M
2
Millennium Management
Millennium Management
New York
+$7.81M
3
ACM
AIGH Capital Management
Maryland
+$5.51M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.05M
5
TLP
Tri Locum Partners
New York
+$4.04M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$30.2M
2
OM
Opaleye Management
Massachusetts
-$6.72M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.6M
4
BBA
Baker Bros. Advisors
New York
-$1.11M
5
EI
EAM Investors
California
-$893K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$27.1M -$30.2M -9,043,323 -52%
CCM
2
Consonance Capital Management
New York
$21.2M +$21.9M +6,575,000 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$11.4M +$4.05M +1,214,113 +52%
Millennium Management
4
Millennium Management
New York
$10.4M +$7.81M +2,341,544 +268%
BlackRock
5
BlackRock
New York
$6.48M +$3.43M +1,029,570 +105%
ACM
6
AIGH Capital Management
Maryland
$5.33M +$5.51M +1,650,256 New
TLP
7
Tri Locum Partners
New York
$3.91M +$4.04M +1,210,863 New
GPC
8
Guardian Point Capital
Virginia
$3.88M +$4M +1,200,000 New
Renaissance Technologies
9
Renaissance Technologies
New York
$3.67M -$3.6M -1,079,907 -49%
Two Sigma Investments
10
Two Sigma Investments
New York
$3.35M +$1.97M +591,482 +133%
JGC
11
J. Goldman & Co
New York
$3.19M +$3.29M +986,138 New
ACM
12
Altium Capital Management
New York
$3.14M +$3.24M +972,327 New
Two Sigma Advisers
13
Two Sigma Advisers
New York
$2.5M +$1.85M +553,200 +250%
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$2.37M -$207K -61,917 -8%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$2.3M +$2.23M +667,072 +1,497%
Marshall Wace
16
Marshall Wace
United Kingdom
$2.24M +$2.31M +691,892 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$2.22M +$1.02M +305,092 +80%
SM
18
Sabby Management
Florida
$1.71M +$1.77M +530,000 New
PIM
19
Platinum Investment Management
Australia
$1.7M -$762K -228,492 -30%
DCM
20
DAFNA Capital Management
California
$1.48M +$1.53M +459,260 New
BCM
21
Bridgeway Capital Management
Texas
$1.33M -$28.4K -8,500 -2%
WVP
22
Worth Venture Partners
New Jersey
$1.25M +$1.29M +387,141 New
Citadel Advisors
23
Citadel Advisors
Florida
$1.22M +$1.26M +377,512 New
Deutsche Bank
24
Deutsche Bank
Germany
$1.16M +$1.2M +358,854 New
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$993K +$551K +165,179 +116%
1
2 3 4

INFI Hedge Fund Activity: Q1 2021 in Review

83 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2021, worth a combined $136M — up 97% from $68.9M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new INFI positions and 9 closed out — a net gain of 29 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $21.9M. The largest seller was BVF Inc, cutting an estimated $30.2M.

  • 83 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2021, up from 55 in Q4 2020.
  • Funds reported $136M of Infinity Pharmaceuticals, Inc. stock for Q1 2021, up 97% quarter-over-quarter.
  • 38 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2021 and 9 closed out, a net change of +29 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2021 was Consonance Capital Management, an estimated $21.9M added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q1 2021 was BVF Inc, an estimated $30.2M sold.

Based on aggregated 13F filings for Q1 2021.